Baxter Recalls Prismaflex Preventative Maintenance Kits Due to Tubing Performance Variability
Baxter Healthcare is recalling Prismaflex Preventative Maintenance Kits and spare part kits because tubing performance variability may cause alarms during or after system self-tests.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as a Class II recall, which corresponds to a 'Severe' severity score under the rubric, particularly given the critical nature of the medical device used for renal replacement therapy.
Plain-English summary
Baxter Healthcare Corporation is recalling 35,175 Preventative Maintenance Kits (G5010007) and spare part kits (G5064801 and G5006203) for Prismaflex Control Units. These products are used for Continuous Renal Replacement Therapy (CRRT). The recall covers all serial numbers.
The recall was initiated because variability in the performance of the tubing in the Prismaflex Control Unit ARPS (Automatic Repositioning System) Pump Assembly may lead to alarm situations during or after a system self-test. The agency has classified this as a Class II recall.
The affected products were distributed worldwide, including the United States (nationwide, Puerto Rico, and Guam) and numerous international locations. Healthcare facilities and users should stop using the affected kits and contact Baxter Healthcare for further instructions.
The recalled product
- Product
- Preventative Maintenance Kits G5010007) and spare part kits (G5064801 and G5006203) - Product Usage: For Prismaflex Control Units, used for Continuous Renal Replacement Therapy (CRRT).
- Manufacturer
- Baxter Healthcare Corporation
- Affected units
- 35,175
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- all serial numbers
Distribution
Part of a larger recall action
This product is one of 4 recalled by Baxter Healthcare Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Baxter Healthcare Corporation
See all →- ModerateBaxter PRO+ Mattress Recalled for UDI Labeling Error
FDA (Devices) · 2026-09-30
- ModerateBaxter Recalls Two VOLARA Systems Due to Potential Flow Rate Inaccuracy
FDA (Devices) · 2026-09-30
- ModerateBaxter Recalls PRO+ MRS Mattress Due to UDI Labeling Error
FDA (Devices) · 2026-09-30
- ModerateBaxter PRO+ 36-inch Mattress Recalled for UDI Labeling Error
FDA (Devices) · 2026-09-30
- SevereBaxter Recalls Dextrose Injection Bags Due to Stainless Steel Particulate Matter
FDA (Drugs) · 2026-09-16
Same hazard · performance variability
See all →- ModerateSiemens ADVIA Centaur iPTH Calibrator Recalled for Variability
FDA (Devices) · 2013-06-12
Similar recalls
- HighBaxter Recalls Prismaflex Control Units Due to Software and Usage Issues
FDA (Devices) · 2018-04-11
- ModerateBaxter Recalls Prismaflex Control Units for Firmware Update
FDA (Devices) · 2018-05-30
- ModerateBaxter Recalls Prismaflex 7.20 US Control Units for Firmware Update
FDA (Devices) · 2018-05-30
- ModerateBaxter Recalls Prismaflex Systems for Pump Module Electronics Failure
FDA (Devices) · 2018-05-30
- HighBaxter Recalls PrisMax Hemodialysis Tubing Due to Performance Variability
FDA (Devices) · 2021-03-10
- SevereBaxter Prismaflex Control Unit Recalled for Potential Therapy Interruption
FDA (Devices) · 2019-11-13